EP. 1: Rationale for BTK Inhibition in CLL
Watch
EP. 2: BTK Inhibition: Disease State Effectiveness
EP. 3: Approved BTK Inhibitors for CLL
EP. 4: CLL Frontline Options
EP. 5: CLL Subpopulations: Whom Not to Give BTK Inhibition To
EP. 6: Time-Limited Therapy Options for BTK Inhibitors
EP. 7: BTK Combination Therapy
EP. 8: BTK Inhibition: Real World vs Clinical Experience
EP. 9: The Management of Cardiovascular Events
EP. 10: BTK Inhibitor Resistance and Progression
EP. 11: The Future of CLL Management
